Pritesh Morar

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 334 citations

Terminal Ileitis, Gastroenterology, Multicentre Trial +4

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 173 citations

Terminal Ileitis, Medicine, C Trial +5

Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease--Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome

Pritesh Morar, J. D. Hodgkinson, S. Thalayasingam et al. · Journal of Crohn s and Colitis · 2015 · 107 citations

Defining the optimal design of the inflammatory bowel disease multidisciplinary team: results from a multicentre qualitative expert-based study

Pritesh Morar, Sonal Arora, Ailsa Hart et al. · Frontline Gastroenterology · 2015 · 41 citations · Full text

Establishing the aims, format and function for multidisciplinary team-driven care within an inflammatory bowel disease service: a multicentre qualitative specialist-based consensus study

Pritesh Morar, Nick Sevdalis, Janindra Warusavitarne et al. · Frontline Gastroenterology · 2017 · 36 citations · Full text